HansBiomed Balance Sheet

Financials in millions KRW. Fiscal year is October - September.

Millions KRW. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	17,954	8,149	7,259	6,132	7,524	7,051
Trading Asset Securities	-	-	-	916.26	6,030	13,217
Cash & Short-Term Investments	17,954	8,149	7,259	7,048	13,553	20,268
Cash Growth	52.83%	12.26%	3.00%	-48.00%	-33.13%	-11.35%
Accounts Receivable	23,187	16,646	11,246	12,091	9,561	7,337
Other Receivables	895.96	595.04	646.92	779.81	459.59	2,388
Receivables	26,912	17,280	11,933	12,903	10,223	9,803
Inventory	29,400	28,833	28,342	27,798	26,936	18,673
Prepaid Expenses	-	794.65	557.28	733.24	579.89	433.2
Other Current Assets	3,507	1,015	1,616	1,911	3,079	1,935
Total Current Assets	77,773	56,072	49,707	50,393	54,371	51,113
Property, Plant & Equipment	42,000	41,724	43,523	44,234	46,934	46,591
Long-Term Investments	5,446	5,728	5,262	4,356	6,222	8,926
Other Intangible Assets	501.18	535.75	794.97	755.83	899.8	1,031
Long-Term Accounts Receivable	2,741	2,375	236.81	0	-	-
Long-Term Deferred Tax Assets	328.57	328.57	2,202	2,318	2,636	734.37
Long-Term Deferred Charges	-	-	-	-	-	89.19
Other Long-Term Assets	19,102	19,588	19,788	20,132	20,464	20,756
Total Assets	147,935	126,407	121,715	122,368	131,686	129,445
Accounts Payable	6,601	5,399	2,274	2,114	1,984	1,204
Accrued Expenses	2,025	1,459	1,096	947.38	841.76	743.93
Short-Term Debt	34,300	35,300	34,300	39,450	53,553	27,300
Current Portion of Long-Term Debt	-	-	-	-	-	9,000
Current Portion of Leases	847.66	807.33	1,130	942.13	1,010	740.52
Current Income Taxes Payable	649.12	509.95	848.17	109.47	320.37	-
Other Current Liabilities	18,205	37,560	10,445	21,691	16,734	22,002
Total Current Liabilities	62,629	81,034	50,092	65,253	74,443	60,991
Long-Term Debt	6,000	6,000	-	-	-	12,879
Long-Term Leases	1,078	1,199	1,000	749.26	1,347	1,658
Other Long-Term Liabilities	4,251	4,287	3,501	6,417	8,441	6,336
Total Liabilities	73,958	92,521	54,593	72,419	84,231	81,863
Common Stock	7,131	6,763	6,763	6,058	5,051	5,051
Additional Paid-In Capital	112,382	82,224	82,224	58,621	32,288	32,288
Retained Earnings	-40,304	-46,323	-14,982	-7,759	15,286	9,139
Treasury Stock	-	-5,833	-5,833	-5,833	-5,055	-884.32
Comprehensive Income & Other	-4,995	-3,127	-1,298	-1,958	-1,937	-1,143
Total Common Equity	74,214	33,704	66,874	49,129	45,634	44,451
Minority Interest	-237.35	182.7	248.39	819.76	1,821	3,130
Shareholders' Equity	73,977	33,887	67,122	49,949	47,455	47,581
Total Liabilities & Equity	147,935	126,407	121,715	122,368	131,686	129,445
Total Debt	42,226	43,307	36,430	41,141	55,910	51,577
Net Cash (Debt)	-24,272	-35,158	-29,171	-34,093	-42,356	-31,309
Net Cash Per Share	-1824.02	-2707.17	-2252.56	-3181.12	-3224.39	-3127.17
Filing Date Shares Outstanding	14.26	12.99	12.99	11.58	9.64	10.01
Total Common Shares Outstanding	14.26	12.99	12.99	11.58	9.64	10.01
Working Capital	15,144	-24,963	-385.31	-14,860	-20,072	-9,878
Book Value Per Share	5204.87	2595.20	5149.32	4243.81	4732.03	4439.82
Tangible Book Value	73,713	33,168	66,079	48,373	44,734	43,420
Tangible Book Value Per Share	5169.72	2553.95	5088.10	4178.52	4638.72	4336.84
Land	12,753	12,571	12,459	12,542	12,525	12,525
Buildings	22,356	22,086	21,925	22,049	17,649	18,110
Machinery	23,266	22,402	20,998	19,869	8,920	7,919
Construction In Progress	1,568	1,429	1,535	1,262	1,043	1,603